Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs03765289

Ligand	Ligand name	Chain	PDB	Tanimoto
HC3	25-HYDROXYCHOLESTEROL	A	1ZHX	0.81
VD1	5-{2-[1-(1-METHYL-PROPYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-2-METHYLENE-CYCLOHEXANE-1,3-DIOL	A	1RKG	0.72
VDY	3-{2-[1-(5-HYDROXY-1,5-DIMETHYL-HEXYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-4-METHYLENE-CYCLOHEXANOL	A,B	1J78	0.78
VDY	3-{2-[1-(5-HYDROXY-1,5-DIMETHYL-HEXYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-4-METHYLENE-CYCLOHEXANOL	A,D	1MZ9	0.78
V2H	(1S,3R,5Z,7E,22E)-9,10-secoergosta-5,7,10,22-tetraene-1,3-diol	A,B	3DL9	0.71
1CA	DESOXYCORTICOSTERONE	A,B	1Y9R	0.7
1CA	DESOXYCORTICOSTERONE	A,B,C	2ABI	0.7
1CA	DESOXYCORTICOSTERONE	A	2Q3Y	0.7
1CA	DESOXYCORTICOSTERONE	A	2AA7	0.7
C3S	CHOLEST-5-EN-3-YL HYDROGEN SULFATE	A	1S0X	0.73
C3S	CHOLEST-5-EN-3-YL HYDROGEN SULFATE	A	2Q9F	0.73
C3S	CHOLEST-5-EN-3-YL HYDROGEN SULFATE	A,B,C	2HKA	0.73
HC2	20-HYDROXYCHOLESTEROL	A	1ZHW	0.81
VD3	(1S,3Z)-3-[(2E)-2-[(1R,3AR,7AS)-7A-METHYL-1-[(2R)-6-METHYLHEPTAN-2-YL]-2,3,3A,5,6,7-HEXAHYDRO-1H-INDEN-4-YLIDENE]ETHYLIDENE]-4-METHYLIDENE-CYCLOHEXAN-1-OL	A	2GJ5	0.77
VD3	(1S,3Z)-3-[(2E)-2-[(1R,3AR,7AS)-7A-METHYL-1-[(2R)-6-METHYLHEPTAN-2-YL]-2,3,3A,5,6,7-HEXAHYDRO-1H-INDEN-4-YLIDENE]ETHYLIDENE]-4-METHYLIDENE-CYCLOHEXAN-1-OL	A,B	3C6G	0.77
CO1	17-[3-(3,3-DIMETHYL-OXIRANYL)-1-METHYL-PROPYL]-10,13-DIMETHYL-2,3,4,7,8,9,10,11,12,13,14,15,16,17-TETRADECAHYDRO-1H-CYCLOPENTA[A]PHENANTHREN-3-OL	A,B	1P8D	0.79
JB1	(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(2R,3S)-3-(2-hydroxyethyl)heptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidene-cyclohexane-1,3-diol	A	2ZXM	0.74
VD5	(1R,3R,7E,17E)-17-(5-hydroxy-1,5-dimethylhexylidene)-2-methylene-9,10-secoestra-5,7-diene-1,3-diol	A	2O4R	0.71
ERG	ERGOSTEROL	A	1BXM	0.79
ERG	ERGOSTEROL	A	1ZHZ	0.79
ERG	ERGOSTEROL	A,B	2AIB	0.79
AON	5-ALPHA-ANDROSTANE-3-BETA,17-ALPHA-DIOL	A	1LHN	0.71
VD2	5-{2-[1-(5-HYDROXY-1,5-DIMETHYL-HEXYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-2-METHYL-CYCLOHEXANE-1,3-DIOL	A	1RKH	0.75
D2V	(3S,5Z,7E,22E)-9,10-secoergosta-5,7,10,22-tetraen-3-ol	A,B	3CZH	0.76
TES	TESTOSTERONE	A	1JTV	0.73
TES	TESTOSTERONE	A	2Q7L	0.73
TES	TESTOSTERONE	A	2Q7I	0.73
TES	TESTOSTERONE	A,B	1J96	0.73
TES	TESTOSTERONE	A	2Q7K	0.73
TES	TESTOSTERONE	A,B	1Q13	0.73
TES	TESTOSTERONE	H	1I9J	0.73
TES	TESTOSTERONE	A,B	1AFS	0.73
TES	TESTOSTERONE	H	1VPO	0.73
TES	TESTOSTERONE	A	2Q7J	0.73
TES	TESTOSTERONE	A,B	3BUR	0.73
TES	TESTOSTERONE	A	2AM9	0.73
AOM	5-ALPHA-ANDROSTANE-3-BETA,17BETA-DIOL	A	1LHO	0.71
O1C	2ALPHA-(3-HYDROXYPROPYL)-1ALPHA,25-DIHYDROXYVITAMIN D3	A	2HB7	0.72
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A,B	1E3R	0.73
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A	3DHE	0.73
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A	1J99	0.73
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A	1COY	0.73
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A	1Q22	0.73
ATE	16,17-ANDROSTENE-3-OL	A,B	1XNX	0.9
C33	2ALPHA-PROPYL-1ALPHA,25-DIHYDROXYVITAMIN D3	A	2HAM	0.73
HCR	7-HYDROXYCHOLESTEROL	A	1ZHT	0.78
CLR	CHOLESTEROL	A,B	2ZXE	0.83
CLR	CHOLESTEROL	A	1N83	0.83
CLR	CHOLESTEROL	A	2RH1	0.83
CLR	CHOLESTEROL	A	1LRI	0.83
CLR	CHOLESTEROL	A	1ZHY	0.83
CLR	CHOLESTEROL	A	3D4S	0.83
VDX	5-{2-[1-(5-HYDROXY-1,5-DIMETHYL-HEXYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-4-METHYLENE-CYCLOHEXANE-1,3-DIOL	A	2ZBZ	0.73
VDX	5-{2-[1-(5-HYDROXY-1,5-DIMETHYL-HEXYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-4-METHYLENE-CYCLOHEXANE-1,3-DIOL	A	1RK3	0.73
VDX	5-{2-[1-(5-HYDROXY-1,5-DIMETHYL-HEXYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-4-METHYLENE-CYCLOHEXANE-1,3-DIOL	A	1DB1	0.73
VDX	5-{2-[1-(5-HYDROXY-1,5-DIMETHYL-HEXYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-4-METHYLENE-CYCLOHEXANE-1,3-DIOL	A	1IE9	0.73
VDX	5-{2-[1-(5-HYDROXY-1,5-DIMETHYL-HEXYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-4-METHYLENE-CYCLOHEXANE-1,3-DIOL	A	2HC4	0.73
VDX	5-{2-[1-(5-HYDROXY-1,5-DIMETHYL-HEXYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-4-METHYLENE-CYCLOHEXANE-1,3-DIOL	A	2ZLC	0.73
VDX	5-{2-[1-(5-HYDROXY-1,5-DIMETHYL-HEXYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-4-METHYLENE-CYCLOHEXANE-1,3-DIOL	A	3CV9	0.73
JC1	(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(2S,3S)-3-(2-hydroxyethyl)heptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidene-cyclohexane-1,3-diol	A	2ZXN	0.74
PLO	(3BETA)-3-HYDROXYPREGN-5-EN-20-ONE	A	1Q20	0.74
VDZ	5-{2-[1-(5-HYDROXY-1,5-DIMETHYL-HEXYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-2-METHYLENE-CYCLOHEXANE-1,3-DIOL	A	1RJK	0.73
LAN	LANOSTEROL	A	1W6K	0.85
MC9	CALCIPOTRIOL	A	1S19	0.72
FFA	(10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE	A,B	2IPG	0.73
FFA	(10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE	A,B	2IPJ	0.73
FFA	(10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE	A,B	2IPF	0.73
BIV	21-NOR-9,10-SECOCHOLESTA-5,7,10(19)-TRIENE-1,3,25-TRIOL, 20-(4-HYDROXY-4-METHYLPENTYL)-, (1A,3B,5Z,7E)	A	2HCD	0.71
VD4	(1R,3R,7E,17Z)-17-(5-hydroxy-1,5-dimethylhexylidene)-2-methylene-9,10-secoestra-5,7-diene-1,3-diol	A	2O4J	0.71
MVD	2ALPHA-METHYL-1ALPHA,25-DIHYDROXY-VITAMIN D3	A	2HB8	0.73